Global Benign Prostatic Hyperplasia Treatment Equipments Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • receipt Report ID : 86663
  • calendar_today Published On: Aug, 2020
  • file_copy Pages: 156
  • list Market Research
Buy @ $3500

Market Overview

The Benign Prostatic Hyperplasia Treatment Equipments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Benign Prostatic Hyperplasia Treatment Equipments sales will be xx in 2020 from Benign Prostatic Hyperplasia Treatment Equipments million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Benign Prostatic Hyperplasia Treatment Equipments market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Benign Prostatic Hyperplasia Treatment Equipments industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Benign Prostatic Hyperplasia Treatment Equipments and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation

Benign Prostatic Hyperplasia Treatment Equipments market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Benign Prostatic Hyperplasia Treatment Equipments market has been segmented into:

Surgical Treatment Equipments

Minimally Invasive Treatment Equipments

Laser Treatment Equipments

Other

By Application, Benign Prostatic Hyperplasia Treatment Equipments has been segmented into:

Hospitals and Clinics

Ambulatory Surgical Centers(ASC)

Home

Others

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Benign Prostatic Hyperplasia Treatment Equipments market presented in the report. This section sheds light on the sales growth of different regional and country-level Benign Prostatic Hyperplasia Treatment Equipments markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Benign Prostatic Hyperplasia Treatment Equipments market.

The report offers in-depth assessment of the growth and other aspects of the Benign Prostatic Hyperplasia Treatment Equipments market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Benign Prostatic Hyperplasia Treatment Equipments Market Share Analysis

Benign Prostatic Hyperplasia Treatment Equipments competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Benign Prostatic Hyperplasia Treatment Equipments sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Benign Prostatic Hyperplasia Treatment Equipments sales, revenue and market share for each player covered in this report.

The major players covered in Benign Prostatic Hyperplasia Treatment Equipments are:

Advin Urology

JenaSurgical GmbH

CONMED

Biolitec

HistoSonics, Inc.

Boston Scientific Corporation

LISA Laser Products GmbH

CoreTherm Medical, Inc.

Convergent Laser Technologies

KARL STORZ

NeoTract, Inc.

PROCEPT BioRobotics

Lumenis Ltd.

Sophiris Bio, Inc.

Olympus Corporation

Merit Medical Systems, Inc.

Medifocus, Inc

Richard Wolf GmbH

Pnn Medical AS

Medtronic plc

Stryker Corporation

Among other players domestic and global, Benign Prostatic Hyperplasia Treatment Equipments market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Benign Prostatic Hyperplasia Treatment Equipments Market Overview

1.1 Product Overview and Scope of Benign Prostatic Hyperplasia Treatment Equipments

1.2 Classification of Benign Prostatic Hyperplasia Treatment Equipments by Type

1.2.1 Global Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Type in 2019

1.2.3 Surgical Treatment Equipments

1.2.4 Minimally Invasive Treatment Equipments

1.2.5 Laser Treatment Equipments

1.2.6 Other

1.3 Global Benign Prostatic Hyperplasia Treatment Equipments Market by Application

1.3.1 Overview: Global Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Hospitals and Clinics

1.3.3 Ambulatory Surgical Centers(ASC)

1.3.4 Home

1.3.5 Others

1.4 Global Benign Prostatic Hyperplasia Treatment Equipments Market by Regions

1.4.1 Global Benign Prostatic Hyperplasia Treatment Equipments Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of Benign Prostatic Hyperplasia Treatment Equipments (2015-2025)

1.4.3 North America (USA, Canada and Mexico) Benign Prostatic Hyperplasia Treatment Equipments Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) Benign Prostatic Hyperplasia Treatment Equipments Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Benign Prostatic Hyperplasia Treatment Equipments Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) Benign Prostatic Hyperplasia Treatment Equipments Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Benign Prostatic Hyperplasia Treatment Equipments Status and Prospect (2015-2025)

1.5 COVID-19 Outbreak: Benign Prostatic Hyperplasia Treatment Equipments Industry Impact

1.5.1 COVID-19 Potential Implications for the Benign Prostatic Hyperplasia Treatment Equipments

1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Benign Prostatic Hyperplasia Treatment Equipments

1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April

1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4

1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2

1.5.2 Opportunity Analysis in Covid-19 Crisis

1.5.3 Market Risk and Restraints

1.5.4 Market Driving Force

2 Company Profiles

2.1 Advin Urology

2.1.1 Advin Urology Details

2.1.2 Advin Urology Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Advin Urology SWOT Analysis

2.1.4 Advin Urology Product and Services

2.1.5 Advin Urology Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.2 JenaSurgical GmbH

2.2.1 JenaSurgical GmbH Details

2.2.2 JenaSurgical GmbH Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 JenaSurgical GmbH SWOT Analysis

2.2.4 JenaSurgical GmbH Product and Services

2.2.5 JenaSurgical GmbH Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.3 CONMED

2.3.1 CONMED Details

2.3.2 CONMED Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 CONMED SWOT Analysis

2.3.4 CONMED Product and Services

2.3.5 CONMED Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.4 Biolitec

2.4.1 Biolitec Details

2.4.2 Biolitec Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Biolitec SWOT Analysis

2.4.4 Biolitec Product and Services

2.4.5 Biolitec Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.5 HistoSonics, Inc.

2.5.1 HistoSonics, Inc. Details

2.5.2 HistoSonics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 HistoSonics, Inc. SWOT Analysis

2.5.4 HistoSonics, Inc. Product and Services

2.5.5 HistoSonics, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.6 Boston Scientific Corporation

2.6.1 Boston Scientific Corporation Details

2.6.2 Boston Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Boston Scientific Corporation Product and Services

2.6.4 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.7 LISA Laser Products GmbH

2.7.1 LISA Laser Products GmbH Details

2.7.2 LISA Laser Products GmbH Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 LISA Laser Products GmbH Product and Services

2.7.4 LISA Laser Products GmbH Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.8 CoreTherm Medical, Inc.

2.8.1 CoreTherm Medical, Inc. Details

2.8.2 CoreTherm Medical, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 CoreTherm Medical, Inc. Product and Services

2.8.4 CoreTherm Medical, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.9 Convergent Laser Technologies

2.9.1 Convergent Laser Technologies Details

2.9.2 Convergent Laser Technologies Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Convergent Laser Technologies Product and Services

2.9.4 Convergent Laser Technologies Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.10 KARL STORZ

2.10.1 KARL STORZ Details

2.10.2 KARL STORZ Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 KARL STORZ Product and Services

2.10.4 KARL STORZ Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.11 NeoTract, Inc.

2.11.1 NeoTract, Inc. Details

2.11.2 NeoTract, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 NeoTract, Inc. Product and Services

2.11.4 NeoTract, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.12 PROCEPT BioRobotics

2.12.1 PROCEPT BioRobotics Details

2.12.2 PROCEPT BioRobotics Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 PROCEPT BioRobotics Product and Services

2.12.4 PROCEPT BioRobotics Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.13 Lumenis Ltd.

2.13.1 Lumenis Ltd. Details

2.13.2 Lumenis Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Lumenis Ltd. Product and Services

2.13.4 Lumenis Ltd. Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.14 Sophiris Bio, Inc.

2.14.1 Sophiris Bio, Inc. Details

2.14.2 Sophiris Bio, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 Sophiris Bio, Inc. Product and Services

2.14.4 Sophiris Bio, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.15 Olympus Corporation

2.15.1 Olympus Corporation Details

2.15.2 Olympus Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.15.3 Olympus Corporation Product and Services

2.15.4 Olympus Corporation Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.16 Merit Medical Systems, Inc.

2.16.1 Merit Medical Systems, Inc. Details

2.16.2 Merit Medical Systems, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.16.3 Merit Medical Systems, Inc. Product and Services

2.16.4 Merit Medical Systems, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.17 Medifocus, Inc

2.17.1 Medifocus, Inc Details

2.17.2 Medifocus, Inc Major Business and Total Revenue (Financial Highlights) Analysis

2.17.3 Medifocus, Inc Product and Services

2.17.4 Medifocus, Inc Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.18 Richard Wolf GmbH

2.18.1 Richard Wolf GmbH Details

2.18.2 Richard Wolf GmbH Major Business and Total Revenue (Financial Highlights) Analysis

2.18.3 Richard Wolf GmbH Product and Services

2.18.3 Richard Wolf GmbH Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.19 Pnn Medical AS

2.19.1 Pnn Medical AS Details

2.19.2 Pnn Medical AS Major Business and Total Revenue (Financial Highlights) Analysis

2.19.3 Pnn Medical AS Product and Services

2.19.4 Pnn Medical AS Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.20 Medtronic plc

2.20.1 Medtronic plc Details

2.20.2 Medtronic plc Major Business and Total Revenue (Financial Highlights) Analysis

2.20.3 Medtronic plc Product and Services

2.20.4 Medtronic plc Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

2.21 Stryker Corporation

2.21.1 Stryker Corporation Details

2.21.2 Stryker Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.21.3 Stryker Corporation Product and Services

2.21.4 Stryker Corporation Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Benign Prostatic Hyperplasia Treatment Equipments Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 Benign Prostatic Hyperplasia Treatment Equipments Players Market Share

3.2.2 Top 10 Benign Prostatic Hyperplasia Treatment Equipments Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global Benign Prostatic Hyperplasia Treatment Equipments Revenue and Market Share by Regions

4.2 North America Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

4.3 Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

4.5 South America Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

5 North America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Countries

5.1 North America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Countries (2015-2020)

5.2 USA Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

5.3 Canada Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

5.4 Mexico Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

6 Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue by Countries

6.1 Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue by Countries (2015-2020)

6.2 Germany Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

6.3 UK Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

6.4 France Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

6.5 Russia Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

6.6 Italy Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue by Countries

7.1 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue by Countries (2015-2020)

7.2 China Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

7.3 Japan Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

7.4 Korea Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

7.5 India Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

8 South America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Countries

8.1 South America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Countries (2015-2020)

8.2 Brazil Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

8.3 Argentina Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Benign Prostatic Hyperplasia Treatment Equipments by Countries

9.1 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue by Countries (2015-2020)

9.2 Saudi Arabia Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

9.3 UAE Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

9.4 Egypt Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

9.5 South Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global Benign Prostatic Hyperplasia Treatment Equipments Revenue and Market Share by Type (2015-2020)

10.2 Global Benign Prostatic Hyperplasia Treatment Equipments Market Forecast by Type (2019-2024)

10.3 Surgical Treatment Equipments Revenue Growth Rate (2015-2025)

10.4 Minimally Invasive Treatment Equipments Revenue Growth Rate (2015-2025)

10.5 Laser Treatment Equipments Revenue Growth Rate (2015-2025)

10.6 Other Revenue Growth Rate (2015-2025)

11 Global Benign Prostatic Hyperplasia Treatment Equipments Market Segment by Application

11.1 Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Application (2015-2020)

11.2 Benign Prostatic Hyperplasia Treatment Equipments Market Forecast by Application (2019-2024)

11.3 Hospitals and Clinics Revenue Growth (2015-2020)

11.4 Ambulatory Surgical Centers(ASC) Revenue Growth (2015-2020)

11.5 Home Revenue Growth (2015-2020)

11.6 Others Revenue Growth (2015-2020)

12 Global Benign Prostatic Hyperplasia Treatment Equipments Market Size Forecast (2021-2025)

12.1 Global Benign Prostatic Hyperplasia Treatment Equipments Market Size Forecast (2021-2025)

12.2 Global Benign Prostatic Hyperplasia Treatment Equipments Market Forecast by Regions (2021-2025)

12.3 North America Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Forecast (2021-2025)

12.4 Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Forecast (2021-2025)

12.6 South America Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Benign Prostatic Hyperplasia Treatment Equipments by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Global Benign Prostatic Hyperplasia Treatment Equipments Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. Advin Urology Corporate Information, Location and Competitors

Table 7. Advin Urology Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 8. Advin Urology Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 9. Advin Urology SWOT Analysis

Table 10. Advin Urology Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 11. Advin Urology Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 12. JenaSurgical GmbH Corporate Information, Location and Competitors

Table 13. JenaSurgical GmbH Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 14. JenaSurgical GmbH Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2018-2019)

Table 15. JenaSurgical GmbH SWOT Analysis

Table 16. JenaSurgical GmbH Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 17. JenaSurgical GmbH Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 18. CONMED Corporate Information, Location and Competitors

Table 19. CONMED Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 20. CONMED Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 21. CONMED SWOT Analysis

Table 22. CONMED Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 23. CONMED Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 24. Biolitec Corporate Information, Location and Competitors

Table 25. Biolitec Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 26. Biolitec Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 27. Biolitec SWOT Analysis

Table 28. Biolitec Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 29. Biolitec Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 30. HistoSonics, Inc. Corporate Information, Location and Competitors

Table 31. HistoSonics, Inc. Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 32. HistoSonics, Inc. Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 33. HistoSonics, Inc. SWOT Analysis

Table 34. HistoSonics, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 35. HistoSonics, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 36. Boston Scientific Corporation Corporate Information, Location and Competitors

Table 37. Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 38. Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 39. Boston Scientific Corporation SWOT Analysis

Table 40. Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 41. Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 42. LISA Laser Products GmbH Corporate Information, Location and Competitors

Table 43. LISA Laser Products GmbH Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 44. LISA Laser Products GmbH Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 45. LISA Laser Products GmbH SWOT Analysis

Table 46. LISA Laser Products GmbH Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 47. LISA Laser Products GmbH Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 48. CoreTherm Medical, Inc. Corporate Information, Location and Competitors

Table 49. CoreTherm Medical, Inc. Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 50. CoreTherm Medical, Inc. Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 51. CoreTherm Medical, Inc. SWOT Analysis

Table 52. CoreTherm Medical, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 53. CoreTherm Medical, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 54. Convergent Laser Technologies Corporate Information, Location and Competitors

Table 55. Convergent Laser Technologies Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 56. Convergent Laser Technologies Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 57. Convergent Laser Technologies SWOT Analysis

Table 58. Convergent Laser Technologies Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 59. Convergent Laser Technologies Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 60. KARL STORZ Corporate Information, Location and Competitors

Table 61. KARL STORZ Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 62. KARL STORZ Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 63. KARL STORZ SWOT Analysis

Table 64. KARL STORZ Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 65. KARL STORZ Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 66. NeoTract, Inc. Corporate Information, Location and Competitors

Table 67. NeoTract, Inc. Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 68. NeoTract, Inc. Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 69. NeoTract, Inc. SWOT Analysis

Table 70. NeoTract, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 71. NeoTract, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 72. PROCEPT BioRobotics Corporate Information, Location and Competitors

Table 73. PROCEPT BioRobotics Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 74. PROCEPT BioRobotics Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 75. PROCEPT BioRobotics SWOT Analysis

Table 76. PROCEPT BioRobotics Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 77. PROCEPT BioRobotics Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 78. Lumenis Ltd. Corporate Information, Location and Competitors

Table 79. Lumenis Ltd. Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 80. Lumenis Ltd. Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 81. Lumenis Ltd. SWOT Analysis

Table 82. Lumenis Ltd. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 83. Lumenis Ltd. Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 84. Sophiris Bio, Inc. Corporate Information, Location and Competitors

Table 85. Sophiris Bio, Inc. Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 86. Sophiris Bio, Inc. Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 87. Sophiris Bio, Inc. SWOT Analysis

Table 88. Sophiris Bio, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 89. Sophiris Bio, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 90. Olympus Corporation Corporate Information, Location and Competitors

Table 91. Olympus Corporation Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 92. Olympus Corporation Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 93. Olympus Corporation SWOT Analysis

Table 94. Olympus Corporation Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 95. Olympus Corporation Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 96. Merit Medical Systems, Inc. Corporate Information, Location and Competitors

Table 97. Merit Medical Systems, Inc. Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 98. Merit Medical Systems, Inc. Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 99. Merit Medical Systems, Inc. SWOT Analysis

Table 100. Merit Medical Systems, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 101. Merit Medical Systems, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 102. Medifocus, Inc Corporate Information, Location and Competitors

Table 103. Medifocus, Inc Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 104. Medifocus, Inc Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 105. Medifocus, Inc SWOT Analysis

Table 106. Medifocus, Inc Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 107. Medifocus, Inc Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 108. Richard Wolf GmbH Benign Prostatic Hyperplasia Treatment Equipments Type and Application

Table 109. Richard Wolf GmbH Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 110. Richard Wolf GmbH Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 111. Richard Wolf GmbH SWOT Analysis

Table 112. Richard Wolf GmbH Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 113. Richard Wolf GmbH Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 114. Pnn Medical AS Corporate Information, Location and Competitors

Table 115. Pnn Medical AS Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 116. Pnn Medical AS Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 117. Pnn Medical AS SWOT Analysis

Table 118. Pnn Medical AS Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 119. Pnn Medical AS Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 120. Medtronic plc Corporate Information, Location and Competitors

Table 121. Medtronic plc Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 122. Medtronic plc Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 123. Medtronic plc SWOT Analysis

Table 124. Medtronic plc Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 125. Medtronic plc Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 126. Stryker Corporation Corporate Information, Location and Competitors

Table 127. Stryker Corporation Benign Prostatic Hyperplasia Treatment Equipments Major Business

Table 128. Stryker Corporation Benign Prostatic Hyperplasia Treatment Equipments Total Revenue (USD Million) (2017-2018)

Table 129. Stryker Corporation SWOT Analysis

Table 130. Stryker Corporation Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 131. Stryker Corporation Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 132. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) by Players (2015-2020)

Table 133. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Players (2015-2020)

Table 134. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) by Regions (2015-2020)

Table 135. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Regions (2015-2020)

Table 136. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Countries (2015-2020)

Table 137. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries (2015-2020)

Table 138. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) by Countries (2015-2020)

Table 139. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) by Countries (2015-2020)

Table 140. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Countries (2015-2020)

Table 141. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries (2015-2020)

Table 142. Middle East and Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) by Countries (2015-2020)

Table 143. Middle East and Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries (2015-2020)

Table 144. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) by Type (2015-2020)

Table 145. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Type (2015-2020)

Table 146. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Forecast by Type (2021-2025)

Table 147. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2015-2020)

Table 148. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Application (2015-2020)

Table 149. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Forecast by Application (2021-2025)

Table 150. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Benign Prostatic Hyperplasia Treatment Equipments Picture

Figure 2. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Type in 2019

Figure 3. Surgical Treatment Equipments Picture

Figure 4. Minimally Invasive Treatment Equipments Picture

Figure 5. Laser Treatment Equipments Picture

Figure 6. Other Picture

Figure 7. Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Application in 2019

Figure 8. Hospitals and Clinics Picture

Figure 9. Ambulatory Surgical Centers(ASC) Picture

Figure 10. Home Picture

Figure 11. Others Picture

Figure 12. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million) and Growth Rate (2015-2025)

Figure 13. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) and Growth Rate (2015-2025)

Figure 14. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) and Growth Rate (2015-2025)

Figure 15. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) and Growth Rate (2015-2025)

Figure 16. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) and Growth Rate (2015-2025)

Figure 17. Middle East and Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) and Growth Rate (2015-2025)

Figure 18. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) and Growth Rate (2015-2025)

Figure 19. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Players in 2019

Figure 20. Global Top 5 Players Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share in 2019

Figure 21. Global Top 10 Players Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share in 2019

Figure 22. Key Players Market Share Trend

Figure 23. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 24. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Regions (2015-2020)

Figure 25. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Regions in 2018

Figure 26. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 27. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 28. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 29. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 30. Middle East and Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 31. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries (2015-2020)

Figure 32. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries in 2019

Figure 33. USA Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 34. Canada Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 35. Mexico Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 36. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries (2015-2020)

Figure 37. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries in 2019

Figure 38. Germany Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 39. UK Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 40. France Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 41. Russia Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 42. Italy Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 43. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries (2015-2020)

Figure 44. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries in 2019

Figure 45. China Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 46. Japan Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 47. Korea Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 48. India Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 49. Southeast Asia Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 50. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries (2015-2020)

Figure 51. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries in 2019

Figure 52. Brazil Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 53. Argentina Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 54. Middle East and Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries (2015-2020)

Figure 55. Middle East and Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Countries in 2019

Figure 56. Saudi Arabia Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 57. UAE Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 58. Egypt Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 59. South Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2015-2020)

Figure 60. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Type (2015-2020)

Figure 61. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Type in 2019

Figure 62. Global Benign Prostatic Hyperplasia Treatment Equipments Market Share Forecast by Type (2021-2025)

Figure 63. Global Surgical Treatment Equipments Revenue Growth Rate (2015-2020)

Figure 64. Global Minimally Invasive Treatment Equipments Revenue Growth Rate (2015-2020)

Figure 65. Global Laser Treatment Equipments Revenue Growth Rate (2015-2020)

Figure 66. Global Other Revenue Growth Rate (2015-2020)

Figure 67. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Application (2015-2020)

Figure 68. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Application in 2019

Figure 69. Global Benign Prostatic Hyperplasia Treatment Equipments Market Share Forecast by Application (2021-2025)

Figure 70. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)

Figure 71. Global Ambulatory Surgical Centers(ASC) Revenue Growth Rate (2015-2020)

Figure 72. Global Home Revenue Growth Rate (2015-2020)

Figure 73. Global Others Revenue Growth Rate (2015-2020)

Figure 74. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 75. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 76. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share Forecast by Regions (2021-2025)

Figure 77. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Forecast (2021-2025)

Figure 78. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Forecast (2021-2025)

Figure 79. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Forecast (2021-2025)

Figure 80. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Forecast (2021-2025)

Figure 81. Middle East and Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Forecast (2021-2025)

Figure 82. Sales Channel: Direct Channel vs Indirect Channel